e-Drug3D

1621

ESLICARBAZEPINE ACETATE


INN
ESLICARBAZEPINE ACETATE

(has an active metabolite)

cas 236395-14-5
CLASS

NERVOUS SYSTEM
ANTIEPILEPTICS

ROUTE (list)

ORAL

ATC code

N03AF04

PK parameters

Target

TARGET VOLTAGE-GATED SODIUM CHANNELS

DrugCentral

Sodium channel alpha subunit UNIPROT P35498 SCN1A

Download SDF file (S)-10-Acetoxy-10,11-dihydro-5Hdibenz[b,f]azepine-5-carboxamide

Formula:
C17H16N2O3

Calculated chemical properties:

MW 296.32
NB_atoms 22
XLogP 3.06
PSA 64.12
NB_HD 2
NB_HA 5
fsp3 0.18
Lipinski(0=no;1=yes) 1

FDA
NDA 022416 (label) INN (ESLICARBAZEPINE ACETATE) APTIOM (SUMITOMO PHARMA AM) APPROVAL= AP YEAR= 2013
NDA 211238 (pdf not found) INN (ESLICARBAZEPINE ACETATE) ESLICARBAZEPINE ACETATE (DR REDDYS) APPROVAL= AP YEAR= 2021
NDA 211199 (pdf not found) INN (ESLICARBAZEPINE ACETATE) ESLICARBAZEPINE ACETATE (ALKEM LABS LTD) APPROVAL= AP YEAR= 2023
NDA 216481 (pdf not found) INN (ESLICARBAZEPINE ACETATE) ESLICARBAZEPINE ACETATE (AUROBINDO PHARMA LTD) APPROVAL= TA YEAR= 2023
NDA 211186 (pdf not found) INN (ESLICARBAZEPINE ACETATE) ESLICARBAZEPINE ACETATE (HETERO LABS LTD V) APPROVAL= AP YEAR= 2023
NDA 211236 (pdf not found) INN (ESLICARBAZEPINE ACETATE) ESLICARBAZEPINE ACETATE (APOTEX) APPROVAL= AP YEAR= 2023
NDA 211227 (pdf not found) INN (ESLICARBAZEPINE ACETATE) ESLICARBAZEPINE ACETATE (TORRENT) APPROVAL= AP YEAR= 2024
NDA 211246 (pdf not found) INN (ESLICARBAZEPINE ACETATE) ESLICARBAZEPINE ACETATE (LUPIN) APPROVAL= AP YEAR= 2024
NDA 211219 (pdf not found) INN (ESLICARBAZEPINE ACETATE) ESLICARBAZEPINE ACETATE (JUBILANT GENERICS) APPROVAL= AP YEAR= 2025
NDA 211247 (pdf not found) INN (ESLICARBAZEPINE ACETATE) ESLICARBAZEPINE ACETATE (SPH ZHONGXI PHARM) APPROVAL= AP YEAR= 2025

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL